Transient leukemia in a newborn without Down syndrome: case report and review of the literature. 2014

Laurence Rozen, and Sophie Huybrechts, and Laurence Dedeken, and Catherine Heijmans, and Barbara Dessars, and Pierre Heimann, and Frédéric Lambert, and Denis F Noubouossie, and Alina Ferster, and Anne Demulder
Laboratory of Hematology and Haemostasis, CHU-Brugmann, Université Libre de Bruxelles (ULB), Place Van Gehuchten 4, 1020, Brussels, Belgium, laurence.rozen@chu-brugmann.be.

Transient neonatal leukemia occurs almost exclusively in Down syndrome babies. We report here the unusual case of a newborn without Down syndrome who presented neonatal transient leukemia and who achieved spontaneously complete remission. Trisomy 21 and GATA1 mutation were both present in leukemic cells. While close follow-up is advised since true leukemia may develop later, the patient is still in remission for 2.5 years. We performed a literature review of 15 other similar cases. CONCLUSIONS Our case of transient leukemia without Down syndrome and the literature review highlight the important role of trisomy 21 and GATA1 mutation in the development of transient neonatal leukemia.

UI MeSH Term Description Entries
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D007955 Leukemoid Reaction A peripheral blood picture resembling that of leukemia or indistinguishable from it on the basis of morphologic appearance alone. (Dorland, 27th ed) Leukemoid Reactions,Reaction, Leukemoid,Reactions, Leukemoid
D008297 Male Males
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D003937 Diagnosis, Differential Determination of which one of two or more diseases or conditions a patient is suffering from by systematically comparing and contrasting results of diagnostic measures. Diagnoses, Differential,Differential Diagnoses,Differential Diagnosis
D004247 DNA A deoxyribonucleotide polymer that is the primary genetic material of all cells. Eukaryotic and prokaryotic organisms normally contain DNA in a double-stranded state, yet several important biological processes transiently involve single-stranded regions. DNA, which consists of a polysugar-phosphate backbone possessing projections of purines (adenine and guanine) and pyrimidines (thymine and cytosine), forms a double helix that is held together by hydrogen bonds between these purines and pyrimidines (adenine to thymine and guanine to cytosine). DNA, Double-Stranded,Deoxyribonucleic Acid,ds-DNA,DNA, Double Stranded,Double-Stranded DNA,ds DNA
D004252 DNA Mutational Analysis Biochemical identification of mutational changes in a nucleotide sequence. Mutational Analysis, DNA,Analysis, DNA Mutational,Analyses, DNA Mutational,DNA Mutational Analyses,Mutational Analyses, DNA
D004314 Down Syndrome A chromosome disorder associated either with an extra CHROMOSOME 21 or an effective TRISOMY for chromosome 21. Clinical manifestations include HYPOTONIA, short stature, BRACHYCEPHALY, upslanting palpebral fissures, epicanthus, Brushfield spots on the iris, protruding tongue, small ears, short, broad hands, fifth finger clinodactyly, single transverse palmar crease, and moderate to severe INTELLECTUAL DISABILITY. Cardiac and gastrointestinal malformations, a marked increase in the incidence of LEUKEMIA, and the early onset of ALZHEIMER DISEASE are also associated with this condition. Pathologic features include the development of NEUROFIBRILLARY TANGLES in neurons and the deposition of AMYLOID BETA-PROTEIN, similar to the pathology of ALZHEIMER DISEASE. (Menkes, Textbook of Child Neurology, 5th ed, p213) Mongolism,Trisomy 21,47,XX,+21,47,XY,+21,Down Syndrome, Partial Trisomy 21,Down's Syndrome,Partial Trisomy 21 Down Syndrome,Trisomy 21, Meiotic Nondisjunction,Trisomy 21, Mitotic Nondisjunction,Trisomy G,Downs Syndrome,Syndrome, Down,Syndrome, Down's
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

Laurence Rozen, and Sophie Huybrechts, and Laurence Dedeken, and Catherine Heijmans, and Barbara Dessars, and Pierre Heimann, and Frédéric Lambert, and Denis F Noubouossie, and Alina Ferster, and Anne Demulder
January 2003, Laboratory hematology : official publication of the International Society for Laboratory Hematology,
Laurence Rozen, and Sophie Huybrechts, and Laurence Dedeken, and Catherine Heijmans, and Barbara Dessars, and Pierre Heimann, and Frédéric Lambert, and Denis F Noubouossie, and Alina Ferster, and Anne Demulder
September 2011, Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion,
Laurence Rozen, and Sophie Huybrechts, and Laurence Dedeken, and Catherine Heijmans, and Barbara Dessars, and Pierre Heimann, and Frédéric Lambert, and Denis F Noubouossie, and Alina Ferster, and Anne Demulder
May 2015, European journal of haematology,
Laurence Rozen, and Sophie Huybrechts, and Laurence Dedeken, and Catherine Heijmans, and Barbara Dessars, and Pierre Heimann, and Frédéric Lambert, and Denis F Noubouossie, and Alina Ferster, and Anne Demulder
August 2012, Journal of pediatric hematology/oncology,
Laurence Rozen, and Sophie Huybrechts, and Laurence Dedeken, and Catherine Heijmans, and Barbara Dessars, and Pierre Heimann, and Frédéric Lambert, and Denis F Noubouossie, and Alina Ferster, and Anne Demulder
February 2001, Clinical genetics,
Laurence Rozen, and Sophie Huybrechts, and Laurence Dedeken, and Catherine Heijmans, and Barbara Dessars, and Pierre Heimann, and Frédéric Lambert, and Denis F Noubouossie, and Alina Ferster, and Anne Demulder
December 2023, International journal of laboratory hematology,
Laurence Rozen, and Sophie Huybrechts, and Laurence Dedeken, and Catherine Heijmans, and Barbara Dessars, and Pierre Heimann, and Frédéric Lambert, and Denis F Noubouossie, and Alina Ferster, and Anne Demulder
December 2001, Archives of pathology & laboratory medicine,
Laurence Rozen, and Sophie Huybrechts, and Laurence Dedeken, and Catherine Heijmans, and Barbara Dessars, and Pierre Heimann, and Frédéric Lambert, and Denis F Noubouossie, and Alina Ferster, and Anne Demulder
September 2019, Pediatric dermatology,
Laurence Rozen, and Sophie Huybrechts, and Laurence Dedeken, and Catherine Heijmans, and Barbara Dessars, and Pierre Heimann, and Frédéric Lambert, and Denis F Noubouossie, and Alina Ferster, and Anne Demulder
May 1989, Wiadomosci lekarskie (Warsaw, Poland : 1960),
Laurence Rozen, and Sophie Huybrechts, and Laurence Dedeken, and Catherine Heijmans, and Barbara Dessars, and Pierre Heimann, and Frédéric Lambert, and Denis F Noubouossie, and Alina Ferster, and Anne Demulder
August 2011, Journal of pediatric hematology/oncology,
Copied contents to your clipboard!